Scholar Rock Holding (SRRK) Assets (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly Assets came in at $535.3 million in Q1 2026, up 31.33% year-on-year from $407.6 million in Q1 2025, and up 32.4% quarter-over-quarter from $404.3 million in Q4 2025.
Scholar Rock Holding (SRRK) Assets (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Assets history runs 10 years deep, the most recent figure standing at $535.3 million for Q1 2026.
- On a quarterly basis, Assets rose 31.33% year-over-year to $535.3 million in Q1 2026; TTM through Mar 2026 was $535.3 million, a 31.33% increase from a year earlier, with the FY2025 full-year figure at $404.3 million, down 14.88% from the prior year.
- Assets improved to $535.3 million in Q1 2026 per SRRK's latest filing, from $404.3 million in the prior quarter.
- Across five years, Assets topped out at $535.3 million in Q1 2026 and bottomed at $179.1 million in Q3 2024.
- The 5-year median for Assets is $340.0 million (2025), against an average of $343.9 million.
- Across the five-year window, Assets tumbled 35.77% in 2023 and jumped 129.84% in 2025, its largest moves.
- Year by year, Assets stood at $358.2 million in 2022, then slipped by 13.16% to $311.0 million in 2023, then jumped by 52.69% to $474.9 million in 2024, then slipped by 14.88% to $404.3 million in 2025, then surged by 32.4% to $535.3 million in 2026.
- Per Business Quant, the three latest SRRK Assets figures stand at $535.3 million (Q1 2026), $404.3 million (Q4 2025), and $411.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - | 535.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 535.25 Mn |
| Dec 31, 2025 | 404.27 Mn |
| Sep 30, 2025 | 411.72 Mn |
| Jun 30, 2025 | 340.05 Mn |
| Mar 31, 2025 | 407.55 Mn |
| Dec 31, 2024 | 474.92 Mn |
| Sep 30, 2024 | 179.13 Mn |
| Jun 30, 2024 | 226.87 Mn |
| Mar 31, 2024 | 267.29 Mn |
| Dec 31, 2023 | 311.04 Mn |
| Sep 30, 2023 | 250.69 Mn |
| Jun 30, 2023 | 284.90 Mn |
| Mar 31, 2023 | 314.72 Mn |
| Dec 31, 2022 | 358.17 Mn |
| Sep 30, 2022 | 390.30 Mn |
| Jun 30, 2022 | 424.13 Mn |
| Mar 31, 2022 | 265.98 Mn |
| Dec 31, 2021 | 304.45 Mn |
| Sep 30, 2021 | 298.39 Mn |
| Jun 30, 2021 | 332.05 Mn |